This page is part of our 2022 average annual return archive: it shows the AQST stock yearly return for calendar year 2022. This metric helps investors evaluate and compare performance among different stocks, over time.
Average annual return should be reviewed alongside overall market trends, and company fundamentals like earnings and revenue. As the saying goes on Wall St., past performance from 2022 does not guarantee future similar returns.
| AQST Stock Yearly Return 2022 Table | ||||||||||||||||||||||||||||||
AQST average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare AQST average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| AQST Share Performance |
| AQST Stock Yearly Return 2022 Chart | |||
Also see: • AQST YTD return • AQST average annual return 10 years | |||
| About Aquestive Therapeutics Inc |
| Aquestive Therapeutics is a pharmaceutical company. Co. is developing orally administered products to deliver various molecules using its proprietary technologies, PharmFilm®. Co.'s products within its central nervous system portfolio, focused on epilepsy, include: Sympazan®, an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy known as Lennox-Gastaut syndrome; and Libervant™, a buccally, or inside of the cheek, administered soluble film formulation of diazepam, used as an alternative to device-dependent rescue therapies, available to patients with refractory epilepsy, which are a rectal gel and nasal sprays. The AQST stock yearly return is shown above.
The yearly return on the AQST stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2022 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the AQST annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| AQST Current Stock Quote |
 Free AQST Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Aquestive Therapeutics (AQST) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
ARAV Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!